
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Cancer Microbiome: Recent Highlights and Knowledge Gaps
Reece J. Knippel, Julia L. Drewes, Cynthia L. Sears
Cancer Discovery (2021) Vol. 11, Iss. 10, pp. 2378-2395
Open Access | Times Cited: 75
Reece J. Knippel, Julia L. Drewes, Cynthia L. Sears
Cancer Discovery (2021) Vol. 11, Iss. 10, pp. 2378-2395
Open Access | Times Cited: 75
Showing 1-25 of 75 citing articles:
Targeting the gut and tumor microbiota in cancer
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 320
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 320
Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study
Yiwen Long, Lanhua Tang, Yangying Zhou, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 250
Yiwen Long, Lanhua Tang, Yangying Zhou, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 250
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 150
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 150
Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
Chiara Falcomatà, Stefanie Bärthel, Günter Schneider, et al.
Cancer Discovery (2023) Vol. 13, Iss. 2, pp. 278-297
Open Access | Times Cited: 97
Chiara Falcomatà, Stefanie Bärthel, Günter Schneider, et al.
Cancer Discovery (2023) Vol. 13, Iss. 2, pp. 278-297
Open Access | Times Cited: 97
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Shaosen Zhang, Xinyi Xiao, Yonglin Yi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 53
Shaosen Zhang, Xinyi Xiao, Yonglin Yi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 53
The microbial landscape of colorectal cancer
Maxwell T. White, Cynthia L. Sears
Nature Reviews Microbiology (2023) Vol. 22, Iss. 4, pp. 240-254
Closed Access | Times Cited: 51
Maxwell T. White, Cynthia L. Sears
Nature Reviews Microbiology (2023) Vol. 22, Iss. 4, pp. 240-254
Closed Access | Times Cited: 51
The oral–gut microbiome axis in health and disease
Benoît J. Kunath, Charlotte De Rudder, Cédric C. Laczny, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 12, pp. 791-805
Closed Access | Times Cited: 23
Benoît J. Kunath, Charlotte De Rudder, Cédric C. Laczny, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 12, pp. 791-805
Closed Access | Times Cited: 23
A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma
Jinhuan Yang, Qikuan He, Fei Lü, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 23
Jinhuan Yang, Qikuan He, Fei Lü, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 23
The Interaction between Intratumoral Microbiome and Immunity Is Related to the Prognosis of Ovarian Cancer
Dashuang Sheng, Kaile Yue, Hongfeng Li, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 22
Dashuang Sheng, Kaile Yue, Hongfeng Li, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 22
Gut microbial metabolites in lung cancer development and immunotherapy: Novel insights into gut-lung axis
Xinpei Li, Shijie Shang, Meng Wu, et al.
Cancer Letters (2024) Vol. 598, pp. 217096-217096
Closed Access | Times Cited: 9
Xinpei Li, Shijie Shang, Meng Wu, et al.
Cancer Letters (2024) Vol. 598, pp. 217096-217096
Closed Access | Times Cited: 9
Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug
Alice Njolke Mafe, Dietrich Büsselberg
Biomedicines (2025) Vol. 13, Iss. 2, pp. 422-422
Open Access | Times Cited: 1
Alice Njolke Mafe, Dietrich Büsselberg
Biomedicines (2025) Vol. 13, Iss. 2, pp. 422-422
Open Access | Times Cited: 1
Tumor microbiome diversity influences papillary thyroid cancer invasion
Lijuan Yuan, Ping Yang, Gang Wei, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 34
Lijuan Yuan, Ping Yang, Gang Wei, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 34
Diet-microbiome interactions in cancer treatment: Opportunities and challenges for precision nutrition in cancer
K. Leigh Greathouse, Madhur Wyatt, Abigail J. Johnson, et al.
Neoplasia (2022) Vol. 29, pp. 100800-100800
Open Access | Times Cited: 31
K. Leigh Greathouse, Madhur Wyatt, Abigail J. Johnson, et al.
Neoplasia (2022) Vol. 29, pp. 100800-100800
Open Access | Times Cited: 31
Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response
Hao Zhang, Li Fu, Xinwen Leiliang, et al.
Cancer Communications (2024) Vol. 44, Iss. 10, pp. 1130-1167
Open Access | Times Cited: 7
Hao Zhang, Li Fu, Xinwen Leiliang, et al.
Cancer Communications (2024) Vol. 44, Iss. 10, pp. 1130-1167
Open Access | Times Cited: 7
The role of short-chain fatty acids in cancer prevention and cancer treatment
Balaraman Kalyanaraman, Gang Cheng, Micaël Hardy
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110172-110172
Open Access | Times Cited: 6
Balaraman Kalyanaraman, Gang Cheng, Micaël Hardy
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110172-110172
Open Access | Times Cited: 6
Tumor microenvironment‐regulating nanomedicine design to fight multi‐drug resistant tumors
Qinqin Xu, Xinyue Lan, Huimin Lin, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2022) Vol. 15, Iss. 1
Closed Access | Times Cited: 26
Qinqin Xu, Xinyue Lan, Huimin Lin, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2022) Vol. 15, Iss. 1
Closed Access | Times Cited: 26
Bladder cancer-associated microbiota: Recent advances and future perspectives
Wentao Zhang, Fuhan Yang, Shiyu Mao, et al.
Heliyon (2023) Vol. 9, Iss. 1, pp. e13012-e13012
Open Access | Times Cited: 15
Wentao Zhang, Fuhan Yang, Shiyu Mao, et al.
Heliyon (2023) Vol. 9, Iss. 1, pp. e13012-e13012
Open Access | Times Cited: 15
Advances and challenges of first-line immunotherapy for non-small cell lung cancer: A review
Haiyang Guo, Jun Zhang, Chao Qin, et al.
Medicine (2024) Vol. 103, Iss. 3, pp. e36861-e36861
Open Access | Times Cited: 5
Haiyang Guo, Jun Zhang, Chao Qin, et al.
Medicine (2024) Vol. 103, Iss. 3, pp. e36861-e36861
Open Access | Times Cited: 5
No Bacterial Biomass Detected in Tissue From Patients With Ovarian Cancer and Serous Tubal Intraepithelial Carcinomas Using 16S rDNA Sequencing
Kasper Ingerslev, Tim Svenstrup Poulsen, Mikael Lenz Strube, et al.
Apmis (2025) Vol. 133, Iss. 1
Closed Access
Kasper Ingerslev, Tim Svenstrup Poulsen, Mikael Lenz Strube, et al.
Apmis (2025) Vol. 133, Iss. 1
Closed Access
Low transthyretin is associated with the poor prognosis of colorectal cancer
Zhe Zhang, Chenhao Hu, Feiyu Shi, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Zhe Zhang, Chenhao Hu, Feiyu Shi, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Associations of the gut, cervical, and vaginal microbiota with cervical cancer: a systematic review and meta-analysis
Wen Qin, Shubin Wang, Min Yan, et al.
BMC Women s Health (2025) Vol. 25, Iss. 1
Open Access
Wen Qin, Shubin Wang, Min Yan, et al.
BMC Women s Health (2025) Vol. 25, Iss. 1
Open Access
Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation
Jiaao Sun, Shiyan Song, Jiahua Liu, et al.
npj Biofilms and Microbiomes (2025) Vol. 11, Iss. 1
Open Access
Jiaao Sun, Shiyan Song, Jiahua Liu, et al.
npj Biofilms and Microbiomes (2025) Vol. 11, Iss. 1
Open Access
The influence of Lactobacillus johnsonii on tumor growth and lymph node metastasis in papillary thyroid carcinoma
Minghao Xie, Tingting Yang, Qiang Liu, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Minghao Xie, Tingting Yang, Qiang Liu, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Etiopathogenesis of ovarian cancer. An inflamm-aging entity?
Manuel Sánchez‐Prieto, Rafael Sánchez-Borrego, Daniel Maria Lubián-López, et al.
Gynecologic Oncology Reports (2022) Vol. 42, pp. 101018-101018
Open Access | Times Cited: 19
Manuel Sánchez‐Prieto, Rafael Sánchez-Borrego, Daniel Maria Lubián-López, et al.
Gynecologic Oncology Reports (2022) Vol. 42, pp. 101018-101018
Open Access | Times Cited: 19
Awareness of intratumoral bacteria and their potential application in cancer treatment
Liang Yin, Qiyan Li, Yulin Liu, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Liang Yin, Qiyan Li, Yulin Liu, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12